使用依替膦酸盐的类固醇治疗患者骨密度增加。 - Suppr

Suppr

超能文献

Increased bone density in patients on steroids with etidronate.

作者信息

Skingle S J, Crisp A J

出版信息

Lancet. 1994 Aug 20;344(8921):543-4. doi: 10.1016/s0140-6736(94)91932-1.

DOI:10.1016/s0140-6736(94)91932-1

PMID:7914635

Abstract

摘要

相似文献

Increased bone density in patients on steroids with etidronate.使用依替膦酸盐的类固醇治疗患者骨密度增加。

Lancet. 1994 Aug 20;344(8921):543-4. doi: 10.1016/s0140-6736(94)91932-1.

A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.一项双盲安慰剂对照研究，以确定间歇性周期性依替膦酸对长期口服皮质类固醇治疗患者骨密度的影响。

Thorax. 1998 May;53(5):351-6. doi: 10.1136/thx.53.5.351.

Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases.钙、维生素D和依替膦酸盐用于预防和治疗风湿性疾病患者的糖皮质激素诱导的骨质疏松症。

Clin Exp Rheumatol. 2003 Jan-Feb;21(1):19-26.

Alendronate increased bone mineral density but did not reduce new fractures in glucocorticoid induced osteoporosis.阿仑膦酸盐可增加骨密度，但不能减少糖皮质激素所致骨质疏松症的新发骨折。

Gut. 1999 Jun;44(6):780-1. doi: 10.1136/gut.44.6.780.

Cyclical etidronate increases lumbar spine bone density in patients on long-term glucocorticosteroid therapy.环磷腺苷葡胺可增加长期接受糖皮质激素治疗患者的腰椎骨密度。

Int J Clin Pract. 1997 Sep;51(6):364-7.

Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study.周期性依替膦酸可增加长期接受皮质类固醇治疗的绝经后妇女脊柱和髋部的骨密度。一项双盲、随机、安慰剂对照研究。

Ann Rheum Dis. 1998 Dec;57(12):724-7. doi: 10.1136/ard.57.12.724.

Etidronate and glucocorticoid induced osteoporosis.依替膦酸二钠与糖皮质激素所致骨质疏松症

J Rheumatol. 2005 Jan;32(1):199-200.

Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.依替膦酸治疗对炎性风湿性疾病患者预防糖皮质激素性骨质流失疗效的评估：一项随机研究。

Rev Rhum Engl Ed. 1999 Apr;66(4):214-9.

[The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].周期性口服依替膦酸在类固醇诱导的骨质疏松症中对骨矿物质密度具有临床益处。

Ryumachi. 2002 Aug;42(4):666-75.

Cyclical etidronate therapy and postgastrectomy osteoporosis.

Br J Surg. 1994 Aug;81(8):1168-9. doi: 10.1002/bjs.1800810828.

引用本文的文献

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松症管理指南制定框架。

Osteoporos Int. 2012 Sep;23(9):2257-76. doi: 10.1007/s00198-012-1958-1. Epub 2012 Mar 21.

Systematic review of trends in prophylaxis of corticosteroid-induced osteoporosis: the need for standard audit guidelines.皮质类固醇诱导骨质疏松症预防趋势的系统评价：对标准审核指南的需求

Osteoporos Int. 2008 Oct;19(10):1379-94. doi: 10.1007/s00198-008-0598-y. Epub 2008 Jul 16.

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.2002年加拿大骨质疏松症诊断与管理临床实践指南。

CMAJ. 2002 Nov 12;167(10 Suppl):S1-34.

Corticosteroid-Induced osteoporosis: detection and management.糖皮质激素性骨质疏松症：检测与管理

Drug Saf. 2001;24(8):607-24. doi: 10.2165/00002018-200124080-00005.

Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.骨质疏松症诊断与管理临床实践指南。加拿大骨质疏松症协会科学咨询委员会。

CMAJ. 1996 Oct 15;155(8):1113-33.

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.骨质疏松症的预防与管理：加拿大骨质疏松症协会科学咨询委员会的共识声明。6. 双膦酸盐类药物在骨质疏松症治疗中的应用

CMAJ. 1996 Oct 1;155(7):945-8.

ABC of rheumatology. Polymyalgia rheumatica and giant cell arteritis.风湿病学基础。风湿性多肌痛和巨细胞动脉炎。

BMJ. 1995 Apr 22;310(6986):1057-9. doi: 10.1136/bmj.310.6986.1057.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验